{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:36:49Z","timestamp":1782927409552,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpsychires.2025.09.030","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:14:08Z","timestamp":1758521648000},"page":"119-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Updated meta-analysis of circulating glial cell line-derived neurotrophic factor levels in major depressive disorder: Clarifying case-control differences and treatment effects"],"prefix":"10.1016","volume":"191","author":[{"given":"Omran","family":"Davarinejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0198-3710","authenticated-orcid":false,"given":"Saeid","family":"Komasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0247-5451","authenticated-orcid":false,"given":"Mohammad-Taher","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Nouraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Kazemisafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpsychires.2025.09.030_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","article-title":"Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.09.030_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/13651501.2020.1723643","article-title":"Exploring the association between depression, suicidality and serum neurotrophin levels in adolescents","volume":"24","author":"Bilgi\u00e7","year":"2020","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pnpbp.2014.08.009","article-title":"Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis","volume":"56","author":"Brunoni","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.030_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pnpbp.2018.06.003","article-title":"Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression","volume":"86","author":"Brunoni","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.09.030_bib5","first-page":"21","article-title":"Relationship of mean platelet volume to MDD: a retrospective study","volume":"29","author":"Cai","year":"2017","journal-title":"Shanghai Arch Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.09.030_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.biopsych.2021.05.008","article-title":"Brain-derived neurotrophic factor signaling in depression and antidepressant action","volume":"90","author":"Castr\u00e9n","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.jpsychires.2025.09.030_bib7","article-title":"Evaluation of serum glial cell line-derived neurotrophic factor in Bangladeshi major depressive disorder patients","volume":"11","author":"Das","year":"2019","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.09.030_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12888-025-06498-9","article-title":"Circulating levels of glial cell line-derived neurotrophic factor (GDNF) in schizophrenia: a systematic review and meta-analysis","volume":"25","author":"Davarinejad","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.030_bib9","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11064-014-1349-4","article-title":"Neurotrophic factors, clinical features and gender differences in depression","volume":"39","author":"de Azevedo Cardoso","year":"2014","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.09.030_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.29271\/jcpsp.2022.03.335","article-title":"Neurotrophic factor levels and cognitive functions before and after the repetitive transcranial magnetic stimulation in treatment resistant depression","volume":"32","author":"Demiroz","year":"2022","journal-title":"J. Coll. Physician Surg. Pak."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.09.030_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpsychires.2011.09.007","article-title":"Circulating Glial-derived neurotrophic factor is reduced in late-life depression","volume":"46","author":"Diniz","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"6103","key":"10.1016\/j.jpsychires.2025.09.030_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jpsychires.2025.09.030_bib13","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.030_bib14","series-title":"Diagnostic and Statistical Manual of Mental Disorders","first-page":"205","author":"Edition","year":"1980"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.09.030_bib15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0037-1613072","article-title":"Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation","volume":"87","author":"Fujimura","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.09.030_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","article-title":"The economic burden of adults with major depressive disorder in the United States (2010 and 2018)","volume":"39","author":"Greenberg","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.09.030_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/13651501.2022.2107938","article-title":"Serum brain-derived neurotrophic factor and glial cell-derived neurotrophic factor in patients with first-episode depression at different ages","volume":"27","author":"He","year":"2023","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.09.030_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41398-020-0843-5","article-title":"Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study","volume":"10","author":"Hidese","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.030_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.jpsychires.2025.09.030_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113967","article-title":"Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response","volume":"301","author":"Idemoto","year":"2021","journal-title":"Psychiatry Res."},{"issue":"7215","key":"10.1016\/j.jpsychires.2025.09.030_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.09.030_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/neu.2015.42","article-title":"Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: a preliminary study","volume":"28","author":"Lee","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpsychires.2015.02.004","article-title":"Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study","volume":"63","author":"Lin","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","article-title":"Changes in the global burden of depression from 1990 to 2017: findings from the global burden of disease study","volume":"126","author":"Liu","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jad.2022.07.041","article-title":"Association between plasma levels of BDNF and GDNF and the diagnosis, treatment response in first-episode MDD","volume":"315","author":"Liu","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2021.103684","article-title":"Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1\/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease","volume":"118","author":"Mesa-Infante","year":"2022","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.09.030_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.eurpsy.2008.06.001","article-title":"Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study","volume":"23","author":"Michel","year":"2008","journal-title":"Eur. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.09.030_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41398-024-02942-8","article-title":"Altered blood parameters in \u201cmajor depression\u201d patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study","volume":"14","author":"Ozkan","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2025.09.030_bib28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.30773\/pi.2018.03.31","article-title":"Alterations in serum BDNF and GDNF levels after 12 Weeks of antidepressant treatment in female outpatients with major depressive disorder","volume":"15","author":"Park","year":"2018","journal-title":"Psychiatry Investig"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.09.030_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.jpsychires.2025.09.030_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12026-014-8491-6","article-title":"Effects of serum and plasma matrices on multiplex immunoassays","volume":"58","author":"Rosenberg-Hasson","year":"2014","journal-title":"Immunol. Res."},{"issue":"7","key":"10.1016\/j.jpsychires.2025.09.030_bib31","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s10072-020-04909-1","article-title":"Do serum GDNF levels correlate with severity of Alzheimer's disease?","volume":"42","author":"Sharif","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","article-title":"Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: a comprehensive review of human studies","volume":"197","author":"Sharma","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","article-title":"Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis","volume":"41","author":"Shi","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.jpsychires.2025.09.030_bib34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jad.2018.11.068","article-title":"Decreased plasma glial cell line-derived neurotrophic factor level in major depressive disorder is associated with age and clinical severity","volume":"245","author":"Sun","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.09.030_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/S1461145705006085","article-title":"Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders","volume":"9","author":"Takebayashi","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pnpbp.2012.09.009","article-title":"Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder","volume":"40","author":"Tseng","year":"2013","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.09.030_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1515\/revneuro-2016-0063","article-title":"Role of glial cell line-derived neurotrophic factor in the pathogenesis and treatment of mood disorders","volume":"28","author":"Tsybko","year":"2017","journal-title":"Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.09.030_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/YCT.0000000000000198","article-title":"A preliminary observation of increased glial cell line-derived neurotrophic factor in manic switch due to electroconvulsive treatment in depressive patients","volume":"31","author":"Tunca","year":"2015","journal-title":"J. ECT"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.09.030_bib39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jad.2011.03.043","article-title":"Association study between plasma GDNF and cognitive function in late-onset depression","volume":"132","author":"Wang","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib40","article-title":"Gray matter volume reduction in orbitofrontal cortex correlated with plasma glial cell line-derived neurotrophic factor (GDNF) levels within major depressive disorder","volume":"37","author":"Wu","year":"2023","journal-title":"Neuroimage: Clinic"},{"key":"10.1016\/j.jpsychires.2025.09.030_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115958","article-title":"Global, regional, and national temporal trend in burden of major depressive disorder from 1990 to 2019: an analysis of the global burden of disease study","volume":"337","author":"Yan","year":"2024","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.09.030_bib42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.pnpbp.2008.01.004","article-title":"Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients","volume":"32","author":"Zhang","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.09.030_bib43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/appy.12120","article-title":"Performance on the Wisconsin card-sorting test and serum levels of glial cell line-derived neurotrophic factor in patients with major depressive disorder","volume":"6","author":"Zhang","year":"2014","journal-title":"Asia Pac. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.09.030_bib44","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1038\/s41598-017-09000-y","article-title":"The protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2025.09.030_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jad.2022.09.025","article-title":"Glial cell line-derived neurotrophic factor (GDNF) in blood serum and lacrimal fluid of patients with a current depressive episode","volume":"318","author":"Zinchuk","year":"2022","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625005539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625005539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:11:40Z","timestamp":1780722700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625005539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":47,"alternative-id":["S0022395625005539"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.09.030","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updated meta-analysis of circulating glial cell line-derived neurotrophic factor levels in major depressive disorder: Clarifying case-control differences and treatment effects","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}